Literature DB >> 15554422

Functional imaging of the brain in patients with liver cirrhosis.

Karin Weissenborn1, Martin Bokemeyer, Björn Ahl, Daniela Fischer-Wasels, Kathrin Giewekemeyer, Jörg van den Hoff, Herbert Köstler, Georg Berding.   

Abstract

Brain imaging techniques have provided substantial insight into the pathophysiology of hepatic encephalopathy (HE). Magnetic resonance imaging gave hint to the fact that there is an increased deposition of manganese especially in the basal ganglia. Single photon emission computed tomography (SPECT) and positron emission tomography (PET) showed that the preference of the basal ganglia might be due to differences in regional cerebral blood flow and an additional redistribution of blood flow from the cortex to subcortical regions in cirrhotics. PET studies using ammonia as tracer showed that the cerebral metabolism of ammonia and the permeability of the blood brain barrier for ammonia is increased in cirrhotic patients compared to healthy controls. The regional ammonia supply is in accordance with the regional blood flow. In accordance with these findings fluorodesoxyglucose-PET-studies of the brain in cirrhotics showed characteristic alterations of glucose utilisation in the patients with a relative decrease of the glucose utilisation of the cingulate gyrus, the frontomedial, frontolateral, and parieto-occipital cortex, while the glucose utilisation of the basal ganglia, the hippocampus, and the cerebellum was relatively increased. These findings fit well with the clinical characteristics of early stages of HE such as deficits in attention, visuo-spatial orientation, visuo-constructive abilities, motor speed, and accuracy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15554422     DOI: 10.1023/b:mebr.0000043976.17500.8e

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  55 in total

Review 1.  Proton magnetic resonance spectroscopy in portal-systemic encephalopathy.

Authors:  H Köstler
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

2.  Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition.

Authors:  S A Mirowitz; T J Westrich; J D Hirsch
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

Review 3.  An image of the brain in patients with liver disease.

Authors:  A H Lockwood; K Weissenborn; R F Butterworth
Journal:  Curr Opin Neurol       Date:  1997-12       Impact factor: 5.710

4.  Attention deficits in minimal hepatic encephalopathy.

Authors:  K Weissenborn; S Heidenreich; J Ennen; N Rückert; H Hecker
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

5.  Increased manganese concentrations in pallidum of cirrhotic patients.

Authors:  G Pomier-Layrargues; L Spahr; R F Butterworth
Journal:  Lancet       Date:  1995-03-18       Impact factor: 79.321

6.  Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy.

Authors:  A M Catafau; J Kulisevsky; L Bernà; J Pujol; J C Martin; P Otermin; J Balanzó; I Carrió
Journal:  J Nucl Med       Date:  2000-03       Impact factor: 10.057

7.  Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

Authors:  C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

8.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

9.  Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.

Authors:  S D Taylor-Robinson; J Sargentoni; C D Marcus; M Y Morgan; D J Bryant
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

10.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

View more
  17 in total

Review 1.  The brain following transjugular intrahepatic portosystemic shunt: the perspective from neuroimaging.

Authors:  Hui Juan Chen; Gang Zheng; Julian L Wichmann; U Joseph Schoepf; Guang Ming Lu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2015-09-24       Impact factor: 3.584

Review 2.  Energy metabolism in brain cells: effects of elevated ammonia concentrations.

Authors:  Leif Hertz; Geeta Kala
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 3.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

4.  Brain perfusion single photon emission computed tomography abnormalities in patients with minimal hepatic encephalopathy.

Authors:  Hejjaji Venkataramarao Sunil; Bhagwant Rai Mittal; Roshan Kurmi; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

5.  Gut-brain chemokine changes in portal hypertensive rats.

Authors:  Joaquin Merino; Maria-Angeles Aller; Sandra Rubio; Natalia Arias; Maria-Paz Nava; Maria Loscertales; Jaime Arias; Jorge-Luis Arias
Journal:  Dig Dis Sci       Date:  2011-02-24       Impact factor: 3.199

6.  Human (13)N-ammonia PET studies: the importance of measuring (13)N-ammonia metabolites in blood.

Authors:  Susanne Keiding; Michael Sørensen; Ole Lajord Munk; Dirk Bender
Journal:  Metab Brain Dis       Date:  2010-03-09       Impact factor: 3.584

Review 7.  Neurocognitive-neurological complications of liver transplantation: a review.

Authors:  Francesca Campagna; A Biancardi; U Cillo; A Gatta; P Amodio
Journal:  Metab Brain Dis       Date:  2010-03-05       Impact factor: 3.584

Review 8.  Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy.

Authors:  Saul W Brusilow; Raymond C Koehler; Richard J Traystman; Arthur J L Cooper
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 9.  New findings on cerebral ammonia uptake in HE using functional (13)N-ammonia PET.

Authors:  Michael Sørensen; Susanne Keiding
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

10.  Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy.

Authors:  Rajat Dhar; G Bryan Young; Paul Marotta
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.